Genmab
OrganizationHeard in 1 episode across 1 show since Aug 2026
Genmab A/S is an international biotechnology company specializing in the development of antibody therapeutics for the treatment of cancer and other serious diseases. Founded in 1999 and headquartered in Copenhagen, Denmark, the company operates globally with research and development facilities in several countries.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 1 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
What experts have said about Genmab
2 statements · 2 positive
GenmAb exceeded revenue and profit expectations and raised its annual outlook.
“GenmAb makes antibody therapeutics, so reported better than expected revenue, better than expected profit for the second quarter and it also boosted its outlook for the year.”
Open the episode · Kingspan Soars, Daimler Truck Slumps, Genmab JumpsListen at 3:30
GenmAb’s lymphoma program could represent a $600 million opportunity in 2035.
“that could be a $600 million commercial opportunity in 2035, according to Bloomberg Intelligence”
Open the episode · Kingspan Soars, Daimler Truck Slumps, Genmab JumpsListen at 4:02
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Genmab, newest first
